Dr. Robert T. Wendel, M.D.
Retina Specialist (Retina Specialist (Ophthalmology) Physician)
- Medicare participating
At a glance
- Medical school
- University of Michigan Medical School (1979)
- Years since graduation
- 47
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 1,104
Licensed in California since 1980, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1979Medical school: University of Michigan Medical School
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Retina Specialist (Ophthalmology) Physician primary
CA license G043291 (first issued 1980; current) -
Ophthalmology Physician
CA license G43291 (first issued 1980; current) · NV license 6988
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Vitreo-Retinal Medical Group, Inc. (22 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,104
- Services billed
- 58,730
- Patients’ average age
- 78
| Service | Times | Patients |
|---|---|---|
| Injection, faricimab-svoa, 0.1 mg | 24,000 | 92 |
| Imaging of retina | 3,731 | 1,401 |
| Injection, aflibercept, 1 mg | 3,520 | 373 |
| Injection of drug into eye | 2,618 | 634 |
| Injection, ranibizumab, 0.1 mg | 2,443 | 129 |
| Established patient problem focused exam of visual system | 2,247 | 780 |
| Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 1,362 | 83 |
| Established patient complete exam of visual system | 543 | 485 |
| Injection, pegcetacoplan, intravitreal, 1 mg | 345 | 17 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 259 | 254 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Prednisolone Acetate Other prescribers in Sacramento, CA | 62 |
| Ketorolac Tromethamine Other prescribers in Sacramento, CA | 56 |
| Timolol Maleate Other prescribers in Sacramento, CA | 33 |
| Ofloxacin Other prescribers in Sacramento, CA | 24 |
| Latanoprost Other prescribers in Sacramento, CA | 18 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 5 companies reported 9 payments worth $384 in total to this clinician.
| Genentech, Inc. | $121 |
|---|---|
| Apellis Pharmaceuticals, Inc. | $105 |
| Genentech USA, Inc. | $81.24 |
| Astellas Pharma US Inc | $57.61 |
| Amgen Inc. | $19.37 |
| Food and Beverage | $384 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.